Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy

Abstract

Our goal in this work was to illustrate the Epstein-Barr virus (EBV)-modulated global biochemical profile and provide a novel metabolism-related target to improve the therapeutic regimen of nasopharyngeal carcinoma (NPC). We used a metabolomics approach to investigate EBV-modulated metabolic changes, and found that the exogenous overexpression of the EBV… (More)
DOI: 10.1038/onc.2014.32

Topics

8 Figures and Tables

Cite this paper

@inproceedings{Xiao2014TargetingEV, title={Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy}, author={L. Xiao and Z-y Hu and X. Dong and Z. Tan and Wenjia Li and M. Tang and Liqing Chen and L. Yang and Y. Tao and Y Jiang and Junjie Li and Byung-Ju Yi and Bei-bei Li and Shih-Kang Fan and S. You and X. Deng and Frank B Hu and L. Feng and Arndt Bode and Z. Dong and L-q Sun and Y Cao}, booktitle={Oncogene}, year={2014} }